Tag Archive for: Roche’s

Multiple sclerosis

Roche’s meets endpoints in relapsing multiple sclerosis

Roche’s bruton’s tyrosine kinas blocker fenebrutinib has met all endpoints in proof-of-concept study with patients suffering from relapsing-remitting multiple sclerosis.

Read more